Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Kimberly Tupper

Physician Assistant Southaven, MS Physician Assistant

NPI 1437785482 CMS profile 11233484

391 Southcrest Pkwy Ste 200, Southaven, MS 38671

Open in the dashboard

General payments

$3,875

189 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kimberly Tupper of Southaven, MS is reported in the CMS Open Payments database as having received $3,875 across 189 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $347 21
2024 General $325 19
2023 General $523 21
2022 General $749 41
2021 General $1,931 87

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kimberly Tupper
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Kimberly Tupper were reported at $347. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Kimberly Tupper Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $1,931 $132 $37–$438 $132
2022 $749 $155 $48–$522 $149
2023 $523 $167 $52–$557 $160
2024 $325 $178 $55–$600 $164
2025 $347 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Novo Nordisk Inc $568 29 payments
  2. AstraZeneca Pharmaceuticals LP $358 17 payments
  3. Amarin Pharma Inc. $340 20 payments
  4. GlaxoSmithKline, LLC. $303 24 payments
  5. AbbVie, Inc. $301 10 payments
  6. Lilly USA, LLC $289 20 payments
  7. Bayer HealthCare Pharmaceuticals Inc. $247 4 payments
  8. Merck Sharp & Dohme Corporation $217 15 payments
  9. Nestle HealthCare Nutrition Inc. $180 9 payments
  10. Pfizer Inc. $154 10 payments
  11. Other $919 31 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $3,874 188 payments
  2. Education $1 1 payment
Products named General payments · program years 2021–2025
  1. RYBELSUS $477 23 payments
  2. Ozempic $392 23 payments
  3. Vascepa $340 20 payments
  4. TRELEGY ELLIPTA $303 24 payments
  5. BREZTRI $270 13 payments
  6. Kerendia $247 4 payments
  7. MOUNJARO $233 16 payments
  8. UBRELVY $231 5 payments
  9. VERQUVO $188 13 payments
  10. ZEPBOUND $188 13 payments
  11. Other $2,222 115 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 32 drugs

Part D claims

749

Median for Physician Assistant: 241

Drug cost

$48,500

Median for Physician Assistant: $4,110

Branded share of claims

16.4%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ozempic Semaglutide Brand 13 $20,498
Jardiance Empagliflozin Brand 18 $13,792
Farxiga Dapagliflozin Propanediol Brand 12 $7,982
Ezetimibe Generic 16 $602
Levothyroxine Sodium Generic 60 $524
Rosuvastatin Calcium Generic 59 $499
Albuterol Sulfate Hfa Albuterol Sulfate Brand 15 $446
Doxycycline Hyclate Generic 53 $410
Losartan Potassium Generic 30 $363
Atorvastatin Calcium Generic 43 $347

The 10 drugs with the highest cost, of 32 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 99 billing codes

Paid by Medicare

$59,611

Of which drugs: $4,543

Medicare patients

277

Average age 76

Services billed

3,109

186 women, 91 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 53%
Ischemic heart disease 35%
Diabetes 31%
Depression 27%
Chronic kidney disease 24%
Cancer 22%
Atrial fibrillation 20%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Vaccine for influenza for injection into muscle 90662 Office 13 15 $1,208
Injection, methylprednisolone acetate, 40 mg J1030 Office 20 20 $91
Injection, methylprednisolone acetate, 1 mg J1010 Office 14 560 $43
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 34 134 $10

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 13 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
MOUNJARO
  • Lilly USA, LLC $41
$41 — —
FARXIGA
  • AstraZeneca Pharmaceuticals LP $36
$36 12 —
ZEPBOUND
  • Lilly USA, LLC $25
$25 — —
NURTEC ODT
  • PFIZER INC. $22
$22 — —
ZAVZPRET
  • PFIZER INC. $22
$22 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 13 in the dashboard with a free account

Records

189 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Mississippi

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record